PRAX FY 2025 Earnings — Praxis Precision Medicines, Inc. Revenue & Financial Results | Market Cap Arena

PRAXPraxis Precision Medicines, Inc.

$7B

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$140,000

Operating Income

-$326M

Net Income

-$303M

EPS (Diluted)

$-13.48

Cash Flow

Operating Cash Flow

-$249M

Free Cash Flow

-$249M

Stock-Based Comp.

$34M

Balance Sheet

Total Assets

$938M

Total Liabilities

$60M

Stockholders' Equity

$878M

Cash & Equivalents

$357M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$9M	-100.0%
Gross Profit	-$140,000	-$144M	+99.9%
Operating Income	-$326M	-$200M	-63.0%
Net Income	-$303M	-$183M	-65.9%